Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, FVT

Tenth Annual BioPharm Americatm Joins Biotech Week Boston for Incomparable Opportunities in Biotech Partnering



CARLSBAD, Calif. and BOSTON, Oct. 6, 2017 /PRNewswire/ -- Nearly 800 executives from the life science industry attended BioPharm Americatm 2017 life science partnering event in Boston last week. Each year at this event, unmatched networking possibilities combined with two days of one-to-one partnering meetings propel valuable deals in the drug development industry.

The highly successful 2017 event included attendance by delegates from 528 companies representing 32 countries. As well, almost 2,000 one-to-one partnering meetings took place at the event where 812 licensing opportunities were on offer, and there were 45 company presentations.

The tenth annual event was held over two days, September 26?27, at the Sheraton Boston, in conjunction with several Biotech Week Boston events at the Hynes Convention Center including the BioProcess International Conference & Exhibition, Cell & Gene Therapy BioProcessing & Commercialization, and the Xconomy Awards. The Translational Impact Forum hosted by Charles River presented the latest trends in groundbreaking life science research and connected entrepreneurs and researchers to funding, development and commercialization partners. The Startup Toolkit and Pitch Competition provided useful tips and experience to a host of very early-stage biotech startups.

High-level pharma and finance executives spoke on Strategy and Business panels on topics including:

The startup pitch contest, featuring 20 early-stage entrepreneurs, offered a first-place prize including post-show mentorship by top-tier venture capitalists, pharma representatives and private equity investors with the opportunity to return for BioPharm America 2018 to give a full-length presentation. The winner was Sven Karlsson, Co-Founder and Chief Business Officer of Platelet BioGenesis.

BioPharm America 2018 will be held in Boston September 5?6, 2018.

Additional links and information: 
Follow BioPharm America on Twitter:  @EBDGroup (hashtag: #BioPharmUSA).

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group's conferences are run with the support of leading corporations and international trade associations and include:

EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world. Tune into EBD Group's Partnering Insight for timely coverage of news that influences the business strategies of the life science industry.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

For more information please visit www.ebdgroup.com.

For more information, contact: 
Kari Bennett 
EBD Group 
179518@email4pr.com 
(760) 930-0500

SOURCE EBD Group


These press releases may also interest you

at 21:00
Half of all individuals in Canada born with cystic fibrosis will not live past around 50 years of age. Emily Lyons ? successful serial entrepreneur and CEO of multiple Toronto-based companies ? experienced firsthand the reality of this sobering...

at 18:14
A new study released today by the Pacific Research Institute finds that a program to give discounted prescription drugs to poor Americans is riddled with abuse, has created a perverse incentive for providers to profit instead of effectively serve the...

at 17:33
Helix BioPharma Corp. , an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the first quarter of fiscal 2018 ending October 31, 2017. FINANCIAL REVIEW...

at 17:03
DiaMedica Therapeutics Inc. (the "Company") , announces that, subject to TSX Venture Exchange approval, it is undertaking a non-brokered private placement for gross proceeds of approximately CAD$1 million (approximately USD$780,000) with the...

at 16:48
Avion pharmaceuticals, LLC, and their partner company, Acella Pharmaceuticals, recently responded to the recent news surrounding the Avondale Pharmaceuticals product Niacor, a prescription version of niacin.  Avion and Acella were made aware of the...

at 16:36
The Royal Canadian Mounted Police (RCMP) today announced the results of its unfounded sexual assault file review, and outlined actions the organization is taking to strengthen sexual assault investigations, oversight and victim support. Earlier...




News published on 6 october 2017 at 08:30 and distributed by: